Concepedia

Louis J. Diorazio

LJ

28

Publications

1.4K

Citations

20

H-Index

1990

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Eli Lilly (United States)

Novartis (Switzerland)

The University of Texas at Austin

Pfizer (United States)

Louis J. Diorazio is an author at AstraZeneca (United Kingdom) specializing in organic chemistry, engineering, and chemistry.

ORCID

Top concepts

Publications per year

1990–2021

28

Publications

28

Toward a More Holistic Framework for Solvent Selection

Louis J. Diorazio, David R. J. Hose, Neil K. Adlington · Organic Process Research & Development · 2016 · 286 citations

, , +14

C–N Bond Formation between Alcohols and Amines Using an Iron Cyclopentadienone Catalyst

Andrew J. Rawlings, Louis J. Diorazio, Martin Wills · Organic Letters · 2015 · 198 citations

Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing

Benjamin I. Andrews, Firoz D. Antia, Shawn B. Brueggemeier et al. · The Journal of Organic Chemistry · 2020 · 134 citations · Full text

, , +21

Use of (Cyclopentadienone)iron Tricarbonyl Complexes for C–N Bond Formation Reactions between Amines and Alcohols

Thomas J. Brown, Madeleine Cumbes, Louis J. Diorazio et al. · The Journal of Organic Chemistry · 2017 · 81 citations · Full text

, , +13

Enantioselective Nickel‐Catalyzed Intramolecular Allylic Alkenylations Enabled by Reversible Alkenylnickel <i>E</i>/<i>Z</i> Isomerization

Connor Yap, Gabriel M. J. Lenagh‐Snow, Somnath Narayan Karad et al. · Angewandte Chemie International Edition · 2017 · 77 citations · Full text

, , +10

Rows per page

1–5 of 28